Works matching IS 15228517 AND DT 2012 AND VI 14 AND IP 12

Results: 18

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1432, doi. 10.1093/neuonc/nos263

By:

Yan, Wei;
Zhang, Wei;
You, Gan;
Zhang, Junxia;
Han, Lei;
Bao, Zhaoshi;
Wang, Yongzhi;
Liu, Yanwei;
Jiang, Chuanlu;
Kang, Chunsheng;
You, Yongping;
Jiang, Tao

Publication type:

Article

Contents Page.

Published in:: Neuro-Oncology, 2012, v. 14, n. 12, p. NP, doi. 10.1093/neuonc/nos017
Publication type:: Article

The molecular biology of WHO grade I astrocytomas.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1424, doi. 10.1093/neuonc/nos257

By:

Marko, Nicholas F.;
Weil, Robert J.

Publication type:

Article

The effects of radiotherapy on psychosocial and cognitive functioning in adults with a primary brain tumor: a prospective evaluation†.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1485, doi. 10.1093/neuonc/nos244

By:

Kangas, Maria;
Tate, Robyn L.;
Williams, Janet R.;
Smee, Robert I.

Publication type:

Article

Resection of PCNSL, if safely possible, seems to be better than biopsy: challenging a paradigm?

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1423, doi. 10.1093/neuonc/nos293

By:

Nishikawa, Ryo

Publication type:

Article

Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1473, doi. 10.1093/neuonc/nos259

By:

Jansen, Nathalie L.;
Schwartz, Christoph;
Graute, Vera;
Eigenbrod, Sabina;
Lutz, Jürgen;
Egensperger, Rupert;
Pöpperl, Gabriele;
Kretzschmar, Hans A.;
Cumming, Paul;
Bartenstein, Peter;
Tonn, Jörg-Christian;
Kreth, Friedrich-Wilhelm;
la Fougère, Christian;
Thon, Niklas

Publication type:

Article

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1441, doi. 10.1093/neuonc/nos266

By:

Eimer, Sandrine;
Dugay, Frédéric;
Airiau, Kelly;
Avril, Tony;
Quillien, Véronique;
Belaud-Rotureau, Marc-Antoine;
Belloc, Francis

Publication type:

Article

Society news.

Published in:: Neuro-Oncology, 2012, v. 14, n. 12, p. 1527, doi. 10.1093/neuonc/nos294
Publication type:: Article

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1452, doi. 10.1093/neuonc/nos270

By:

Schäfer, Andrea;
Teufel, Julian;
Ringel, Florian;
Bettstetter, Marcus;
Hoepner, Ingrid;
Rasper, Michael;
Gempt, Jens;
Koeritzer, Julia;
Schmidt-Graf, Friederike;
Meyer, Bernhard;
Beier, Christoph P.;
Schlegel, Jürgen

Publication type:

Article

Erratum.

Published in:: Neuro-Oncology, 2012, v. 14, n. 12, p. 1528, doi. 10.1093/neuonc/nos297
Publication type:: Article

A phase I/II trial of vandetanib for patients with recurrent malignant glioma.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1519, doi. 10.1093/neuonc/nos265

By:

Kreisl, Teri N.;
McNeill, Katharine A.;
Sul, Joohee;
Iwamoto, Fabio M.;
Shih, Joanna;
Fine, Howard A.

Publication type:

Article

Cover Page.

Published in:: Neuro-Oncology, 2012, v. 14, n. 12, p. NP, doi. 10.1093/neuonc/nos027
Publication type:: Article

Editorial Board.

Published in:: Neuro-Oncology, 2012, v. 14, n. 12, p. NP, doi. 10.1093/neuonc/nos037
Publication type:: Article

Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase–1 mutation.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1465, doi. 10.1093/neuonc/nos258

By:

Lazovic, Jelena;
Soto, Horacio;
Piccioni, David;
Lo Ru, Jerry R.;
Li, Sichen;
Mirsadraei, Leili;
Yong, William;
Prins, Robert;
Liau, Linda M.;
Ellingson, Benjamin M.;
Cloughesy, Timothy F.;
Lai, Albert;
Pope, Whitney B.

Publication type:

Article

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1511, doi. 10.1093/neuonc/nos264

By:

Lee, Eudocia Q.;
Kuhn, John;
Lamborn, Kathleen R.;
Abrey, Lauren;
DeAngelis, Lisa M.;
Lieberman, Frank;
Robins, H. Ian;
Chang, Susan M.;
Yung, W. K. Alfred;
Drappatz, Jan;
Mehta, Minesh P.;
Levin, Victor A.;
Aldape, Kenneth;
Dancey, Janet E.;
Wright, John J.;
Prados, Michael D.;
Cloughesy, Timothy F.;
Gilbert, Mark R.;
Wen, Patrick Y.

Publication type:

Article

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1503, doi. 10.1093/neuonc/nos256

By:

Franceschi, Enrico;
Stupp, Roger;
van den Bent, Martin J.;
van Herpen, Carla;
Laigle Donadey, Florence;
Gorlia, Thierry;
Hegi, Monika;
Lhermitte, Benoit;
Strauss, Lewis C.;
Allgeier, Anouk;
Lacombe, Denis;
Brandes, Alba A.

Publication type:

Article

Surgery for primary CNS lymphoma? Challenging a paradigm.

Published in:

Neuro-Oncology, 2012, v. 14, n. 12, p. 1481

By:

Weller, Michael;
Martus, Peter;
Roth, Patrick;
Thiel, Eckhard;
Korfel, Agnieszka

Publication type:

Article

Subscription Page.

Published in:: Neuro-Oncology, 2012, v. 14, n. 12, p. NP, doi. 10.1093/neuonc/nos047
Publication type:: Article